Latest Earnings Results: Q1 '26
Estimated EPS
-$0.22
Reported EPS
$2.82
Surprise
+1381.82%
Estimated Rev
$16.34M
Reported Rev
$16.04M
Surprise
-1.84%
$FBIO Q1 '26 Earnings Results & Recap Journey Medical Corporation's total revenues increased 21% year-over-year to $16M in Q1 2026, driven by Emrosi revenues of $6.3M. The net loss narrowed to $2.2M, or $(0.08) per share, for the quarter.
Generated by Stocktwits using AI and company-reported earnings data for Q1 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q2 '26 | -$0.20 | -- | -- | N/A |
Q1 '26 | -$0.22 | $2.82 | 1381.82% | BEAT |
Q4 '25 | $0.11 | -$0.15 | -236.36% | MISSED |
Q3 '25 | -$0.42 | $0.11 | 126.19% | BEAT |
Q2 '25 | -$0.36 | $0.45 | 225.00% | BEAT |